header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-1409
Fish name: gz26Tg
Genotype: gz26Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by gz26Tg
Human Disease Conditions Citations
liver cancer chemical treatment: doxycycline monohydrate Zheng et al., 2014
hepatocellular carcinoma chemical treatment: doxycycline monohydrate Zheng et al., 2014
GENE EXPRESSION
Gene expression in gz26Tg
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in gz26Tg
Phenotype Conditions Figures
gut increased size, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013
liver hyperplastic, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013
liver cdh5 expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver il1b expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver mmp9 expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver fgf1a expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver nrp1a expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver hif1ab expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver tnfa expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver itga2b expression increased amount, abnormal chemical treatment by environment: doxycycline Fig. 6 with image from Zhao et al., 2016
liver increased size, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013
liver neoplastic, abnormal standard conditions Fig. S1 with image from Zheng et al., 2014
liver hepatocellular adenoma increased occurrence, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013
liver hepatocellular adenoma mixed, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013
liver hepatocellular carcinoma increased occurrence, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013
whole organism decreased size, abnormal chemical treatment: drug Fig. 2 with image from Li et al., 2013

CITATIONS  (6)